Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Jan;77(1):106–112. doi: 10.1172/JCI112263

Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.

J Rauch, H Tannenbaum, K Straaton, H Massicotte, J Wild
PMCID: PMC423315  PMID: 3511088

Abstract

Human hybridomas have been produced by fusing peripheral blood lymphocytes from patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) with the GM 4672 human cell line. 262 hybridoma clones from the fusions of four RA and five SLE patients were screened for binding to denatured DNA (dDNA), native DNA, and the Fc fragment of human IgG (HIgG). Of the 17 hybridoma antibodies (nine RA, eight SLE) selected for strong binding to denatured DNA, Fc, or both, five reacted with dDNA only, one with Fc only, and eight with both dDNA and Fc. Hybridoma supernatants exhibiting dual reactivity were absorbed over HIgG and bovine serum albumin (BSA)-Sepharose immunoabsorbent columns. The reactivities to both DNA and HIgG were completely removed by the HIgG column but unaffected by passage over the BSA column, and both DNA binding and rheumatoid factor activities were recovered in the acid eluates from the Sepharose-IgG column. The binding of dual reactive hybridoma autoantibodies to the Fc fragment of HIgG was specifically competed by dDNA and HIgG, providing additional evidence that one antibody may be capable of reacting both as a rheumatoid factor and as an anti-DNA antibody.

Full text

PDF
106

Images in this article

110Image
on p.110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., Arbetter A., Ibanez de Kasep G., Powell R., Tan E. M., Joslin F. Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med. 1980 Jun 1;151(6):1514–1527. doi: 10.1084/jem.151.6.1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Awdeh Z. L., Williamson A. R., Askonas B. A. One cell-one immunoglobulin. Origin of limited heterogeneity of myeloma proteins. Biochem J. 1970 Jan;116(2):241–248. doi: 10.1042/bj1160241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cunliffe D. A., Cox K. O. IgM-autoantibodies against isologous erythrocytes also react with isologous IgG(Fc). Nature. 1980 Aug 14;286(5774):720–722. doi: 10.1038/286720a0. [DOI] [PubMed] [Google Scholar]
  4. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gibson D. M., Taylor B. A., Cherry M. Evidence for close linkage of a mouse light chain marker with the Ly-2,3 locus. J Immunol. 1978 Oct;121(4):1585–1590. [PubMed] [Google Scholar]
  6. Gibson D. Genetic polymorphism of mouse immunoglobulin light chains revealed by isoelectric focusing. J Exp Med. 1976 Jul 1;144(1):298–303. doi: 10.1084/jem.144.1.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hannestad K. GammaM rheumatoid factors reacting with nitrophenyl groups and denatured deoxyribonucleic acid. Ann N Y Acad Sci. 1969 Dec 10;168(1):63–75. doi: 10.1111/j.1749-6632.1969.tb43095.x. [DOI] [PubMed] [Google Scholar]
  8. Hannestad K., Johannessen A. Polyclonal human antibodies to IgG (rheumatoid factors) which cross-react with cell nuclei. Scand J Immunol. 1976;5(5):541–547. doi: 10.1111/j.1365-3083.1976.tb00309.x. [DOI] [PubMed] [Google Scholar]
  9. Hannestad K., Rekvig O. P., Husebekk A. Cross-reacting rheumatoid factors and lupus erythematosus (LE)-factors. Springer Semin Immunopathol. 1981;4(2):133–160. doi: 10.1007/BF01857092. [DOI] [PubMed] [Google Scholar]
  10. Hannestad K., Stollar B. D. Certain rheumatoid factors react with nucleosomes. Nature. 1978 Oct 19;275(5681):671–673. doi: 10.1038/275671a0. [DOI] [PubMed] [Google Scholar]
  11. Hobbs R. N., Lea D. J., Phua K. K., Johnson P. M. Binding of isolated rheumatoid factors to histone proteins and basic polycations. Ann Rheum Dis. 1983 Aug;42(4):435–438. doi: 10.1136/ard.42.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lafer E. M., Valle R. P., Möller A., Nordheim A., Schur P. H., Rich A., Stollar B. D. Z-DNA-specific antibodies in human systemic lupus erythematosus. J Clin Invest. 1983 Feb;71(2):314–321. doi: 10.1172/JCI110771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mason J. C., Venables P. J., Smith P. R., Maini R. N. Characterisation of non-histone nuclear proteins cross reactive with purified rheumatoid factors. Ann Rheum Dis. 1985 May;44(5):287–293. doi: 10.1136/ard.44.5.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Massicotte H., Rauch J., Shoenfeld Y., Tannenbaum H. Influence of fusion cell ratio and cell plating density on production of human-human hybridomas secreting anti-DNA autoantibodies from patients with systemic lupus erythematosus. Hybridoma. 1984 Fall;3(3):215–222. doi: 10.1089/hyb.1984.3.215. [DOI] [PubMed] [Google Scholar]
  15. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  16. Reif A. E. Batch preparation of rabbit gammaG globulin with deae-cellulose. Immunochemistry. 1969 Sep;6(5):723–731. doi: 10.1016/0019-2791(67)90136-x. [DOI] [PubMed] [Google Scholar]
  17. Richards F. F., Konigsberg W. H., Rosenstein R. W., Varga J. M. On the specificity of antibodies. Science. 1975 Jan 17;187(4172):130–137. doi: 10.1126/science.46122. [DOI] [PubMed] [Google Scholar]
  18. Rubin R. L., Balderas R. S., Tan E. M., Dixon F. J., Theofilopoulos A. N. Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity. J Exp Med. 1984 May 1;159(5):1429–1440. doi: 10.1084/jem.159.5.1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rubin R. L., Joslin F. G., Tan E. M. A solid-phase radioimmunoassay for anti-histone antibodies in human sera: comparison with an immunofluorescence assay. Scand J Immunol. 1982 Jan;15(1):63–70. doi: 10.1111/j.1365-3083.1982.tb00622.x. [DOI] [PubMed] [Google Scholar]
  20. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  21. Tan E. M., Robinson J., Robitaille P. Studies on antibodies to histones by immunofluorescence. Scand J Immunol. 1976;5(6-7):811–818. doi: 10.1111/j.1365-3083.1976.tb03030.x. [DOI] [PubMed] [Google Scholar]
  22. Wernick R., LoSpalluto J. J., Fink C. W., Ziff M. Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis. Arthritis Rheum. 1981 Dec;24(12):1501–1511. doi: 10.1002/art.1780241208. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES